Trials / Completed
CompletedNCT01110525
A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives
A Phase I, Double-blind, Randomised, Placebo-controlled, Two-cycle Crossover, Drug-drug Interaction Study to Investigate the Effects of AZD1981 Tablets 400 mg Twice Daily on the PK and PD of Oral Contraceptives in Healthy Female Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to determine whether the treatment with AZD1981 will affect the metabolism of hormones included in oral contraceptives.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD1981 | 4X100 mg per oral, twice daily for 28 days |
| DRUG | Neovletta 21/28 | Once daily with (21) or without (28) pause for bleeding. |
| DRUG | Placebo AZD1981 | 4X100 mg per oral, twice daily for 28 days |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2010-04-26
- Last updated
- 2010-11-18
Locations
2 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01110525. Inclusion in this directory is not an endorsement.